TP73 and neoplasm: Tong et al. also observed that TP73-AS1/miR-125a-3p/ACTN4 regulatory network could mediate the occurrence and development of NSCLC, and miR-125a-3p inhibitor reversed the inhibitory function of silencing TP73-AS1 on tumor growth [26].